Cancer BiologybioRxivPreprint
Circadian regulation of MGMT expression and promoter methylation underlies daily rhythms in TMZ sensitivity in glioblastoma
M. F. Gonzalez-Aponte, A. R. Damato, L. L. Trebucq…·E. D. Herzog
This study shows that TMZ efficacy in glioblastoma varies with time-of-day due to circadian rhythms in MGMT expression and promoter methylation, with optimal treatment at the peak of Bmal1 expression.